BeStock  
Stocks › Biotechnology › SVRA

Savara SVRA

US equityMarket cap rank #3206Biotechnology
$4.26 −$0.95 (-18.23%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.30 +0.94%
Open$4.19
Prev close$5.21
Day range$4.00 – $4.52
Volume17.08M
Market cap$939.86M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$43.54M-43.9% YoY
Net profit-$42.99M-45.4% YoY
Diluted EPS-$0.17-21.4% YoY
Free cash flow-$42.82M-90.0% YoY
Operating cash flow-$42.46M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-29.0MDec '24$-26.6MMar '25$-30.4MJun '25$-29.6MSep '25$-32.2MDec '25$-37.3MMar '26$-40.2MJun '26$-43.0MSep '26

Diluted EPS by quarter

-0.13Dec '24-0.12Mar '25-0.14Jun '25-0.14Sep '25-0.13Dec '25-0.15Mar '26-0.16Jun '26-0.17Sep '26

Free cash flow by quarter

$-23.3MDec '24$-27.2MMar '25$-26.3MJun '25$-22.5MSep '25$-25.1MDec '25$-33.1MMar '26$-30.0MJun '26$-42.8MSep '26

Annual revenue

$257.0KFY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-151.0%
Return on assets-102.9%
Return on invested capital-119.2%
Current ratio8.55
Liabilities / assets30.8%
Cash & investments$129.65M
Total debt$30.24M
Net cash (debt)$99.41M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $43.54M $40.97M $38.14M $122.76M $33.42M
Selling and Admin Expenses $18.54M $18.99M $15.57M $42.06M $12.53M
-General & Admin Expense $18.54M $18.99M $15.57M $42.06M $12.53M
Research & Development $24.95M $21.95M $23.40M $81.40M $20.90M
Depreciation & Amortization & Depletion $56,000.00 $28,000.00 $24,000.00 $87,000.00 -$11,000.00
-Depreciation & Amortization $56,000.00 $28,000.00 $24,000.00 $87,000.00 -$11,000.00
Other Taxes $0.00 $0.00 -$853,000.00 -$784,000.00 $0.00
Operating Profit -$43.54M -$40.97M -$38.14M -$122.76M -$33.42M
Net Non-Operating Interest Income (Expense) $505,000.00 $829,000.00 $1.06M $4.16M $1.20M
Non-Operating Interest Income $505,000.00 $829,000.00 $1.06M $4.16M $1.20M
Other Income (Expense) $48,000.00 -$92,000.00 -$204,000.00 -$236,000.00 -$12,000.00
Gain on Sale of Security $48,000.00 -$92,000.00 -$204,000.00 $310,000.00 -$12,000.00
Special Income (Charges) $0.00 $0.00 $0.00 -$546,000.00 $0.00
Pretax Profit -$42.99M -$40.23M -$37.28M -$118.84M -$32.24M
Net Profit -$42.99M -$40.23M -$37.28M -$118.84M -$32.24M
Profit from Continuing Operations -$42.99M -$40.23M -$37.28M -$118.84M -$32.24M
Net Income to Parent Company -$42.99M -$40.23M -$37.28M -$118.84M -$32.24M
Net Income to Common Stockholders -$42.99M -$40.23M -$37.28M -$118.84M -$32.24M
Basic EPS -$0.17 -$0.16 -$0.15 -$0.53 -$0.13
Diluted EPS -$0.17 -$0.16 -$0.15 -$0.53 -$0.13
-Less:Other Special Charges – – – $546,000.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $155.93M $192.14M $221.65M $253.44M $253.44M
Total Current Assets $142.12M $178.32M $209.27M $241.62M $241.62M
Cash and Cash Equivalents & Short-Term Investments $129.65M $173.03M $202.77M $235.70M $235.70M
-Cash and Cash Equivalents $29.81M $41.80M $38.79M $33.18M $33.18M
-Short Term Investments $99.84M $131.23M $163.98M $202.52M $202.52M
Receivables $1.12M $1.08M $1.05M $1.25M $1.25M
-Taxes Receivable $1.12M $1.08M $1.05M $1.25M $1.25M
Prepaid Assets $9.63M $2.27M $3.82M $3.37M $3.37M
Other Current Assets $1.66M $1.78M $1.37M $892,000.00 $892,000.00
Total Non-Current Assets $13.81M $13.82M $12.38M $11.82M $11.82M
Net PPE $716,000.00 $641,000.00 $130,000.00 $100,000.00 $100,000.00
Goodwill and Other Intangible Assets $11.25M $11.29M $11.36M $11.64M $11.64M
-Other Intangible Assets $11.25M $11.29M $11.36M $11.64M $11.64M
Other Non-Current Assets $1.85M $1.89M $886,000.00 $84,000.00 $84,000.00
Total Liabilities $48.08M $48.48M $45.61M $50.30M $50.30M
Total Current Liabilities $16.63M $17.60M $15.54M $20.40M $20.40M
Payables $4.44M $7.00M $4.50M $5.76M $5.76M
-Accounts Payable $4.44M $7.00M $4.50M $5.76M $5.76M
Current Accrued Expenses $6.53M $6.20M $9.46M $7.72M $7.72M
Short-Term Debt and Capital Lease Obligation $121,000.00 $298,000.00 $44,000.00 $7,000.00 $7,000.00
-Current Capital Lease Obligation $121,000.00 $298,000.00 $44,000.00 $7,000.00 $7,000.00
Other Current Liabilities $193,000.00 $385,000.00 $374,000.00 $362,000.00 $362,000.00
Total Non-Current Liabilities $31.45M $30.88M $30.07M $29.91M $29.91M
Long Term Debt and Capital Lease Obligation $30.24M $30.11M $30.07M $29.91M $29.91M
-Long Term Debt $30.24M $30.11M $30.07M $29.91M $29.91M
Other Non-Current Liabilities $1.21M $770,000.00 – – –
Total Equity $107.85M $143.66M $176.04M $203.13M $203.13M
Stockholders' Equity $107.85M $143.66M $176.04M $203.13M $203.13M
Capital Stock $204,000.00 $204,000.00 $204,000.00 $204,000.00 $204,000.00
-Common Stock $204,000.00 $204,000.00 $204,000.00 $204,000.00 $204,000.00
Additional Paid-In Capital $837.03M $829.59M $821.64M $811.10M $811.10M
Retained Earnings -$728.59M -$685.60M -$645.37M -$608.09M -$608.09M
Gains/Losses Not Affecting Retained Earnings -$797,000.00 -$534,000.00 -$429,000.00 -$87,000.00 -$87,000.00
-Gross PPE – – – $2.43M $2.43M
-Accumulated Depreciation – – – -$2.33M -$2.33M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$42.46M -$29.75M -$33.05M -$101.04M -$25.06M
Net cash flow from continuing operations -$42.46M -$29.75M -$33.05M -$101.04M -$25.06M
Net Income from Continuing Operations -$42.99M -$40.23M -$37.28M -$118.84M -$32.24M
Gain/Loss from Continuing Operations -$192,000.00 $35,000.00 -$12,000.00 $704,000.00 $158,000.00
Depreciation & Depletion & Amortization $96,000.00 $99,000.00 $66,000.00 $87,000.00 -$129,000.00
Other Non-Cash Items $132,000.00 $43,000.00 $160,000.00 $453,000.00 $126,000.00
Change in Working Capital -$6.94M $2.96M -$6.14M $5.00M $2.16M
-Change in Prepaid Assets -$6.84M $1.48M -$639,000.00 $97,000.00 -$2.35M
-Change in Payables and Accrued Expense -$99,000.00 $1.48M -$4.64M $4.81M $3.65M
-Change in Other Current Assets $0.00 $0.00 -$864,000.00 $98,000.00 $866,000.00
Net cash flow from investing $31.01M $32.60M $38.78M -$18.44M -$93.56M
Net Cash Flow from Continuing Investing Activities $31.01M $32.60M $38.78M -$18.44M -$93.56M
Net PPE Purchase and Sale -$353,000.00 -$222,000.00 -$54,000.00 -$22,000.00 -$2,000.00
Net Investment Purchase and Sale $31.37M $32.82M $38.83M -$18.42M -$93.56M
Financing Cash Flow -$385,000.00 $189,000.00 -$195,000.00 $137.81M $135.56M
Net Cash Flow from Continuing Financing Activities -$385,000.00 $189,000.00 -$195,000.00 $137.81M $135.56M
Net Issuance Payments Of Debt $0.00 $0.00 $0.00 $2.37M $0.00
Net Common Stock Issuance -$402,000.00 -$5,000.00 -$240,000.00 $135.09M $135.44M
Proceeds from Stock Option Exercised $17,000.00 $194,000.00 $45,000.00 $349,000.00 $119,000.00
Ending Cash Balance $29.81M $41.80M $38.79M $33.18M $33.18M
Net Change in Cash -$11.84M $3.04M $5.54M $18.33M $16.94M
Beginning Cash Balance $41.80M $38.79M $33.18M $15.13M $16.28M
Effect of Exchange Rate Changes -$153,000.00 -$30,000.00 $74,000.00 -$277,000.00 -$36,000.00
Free Cash Flow -$42.82M -$29.97M -$33.10M -$101.06M -$25.06M

Discussion

No comments yet — be the first to weigh in on SVRA.

Sign in to join the discussion.

Scroll to Top